Richard W. Friesen

Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

Denis Riendeau, M. David Percival, Christine Brideau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 460 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530

Daniel Dubé, Marc Blouin, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 272 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

On the controlled oxidative coupling of glycals: a new strategy for the rapid assembly of oligosaccharides

Richard W. Friesen, Samuel J. Danishefsky · Journal of the American Chemical Society · 1989 · 179 citations

Life Sciences, Biochemistry, Chemistry +12

Biaryl synthesis via suzuki coupling on a solid support

Richard Frenette, Richard W. Friesen · Tetrahedron Letters · 1994 · 175 citations

Natural Sciences, Chemistry, Catalysis +10

MF63 [2-(6-Chloro-1 H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation

Daigen Xu, Steven E. Rowland, Patsy Clark et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 152 citations

Medicine, Medicinal Chemistry, Pharmacology +17